Multicenter, Double-blind, Randomized Controlled Trial of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
Condition: SARS-CoV-2 Infection Interventions: Drug: Tocilizumab (TCZ); Drug: Placebo Sponsors: University Hospital Inselspital, Berne; Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials